Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02367339

Acronym

REASSE

Enrollment

100

Registered

2015-02-20

Start date

2015-02-28

Completion date

2016-05-31

Last updated

2015-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistance, Enterobacteriaceae, Escherichia Coli, Extended-spectrum Betalactamase

Keywords

Critical Care, Nursing staff, Medical staff, Extended-spectrum betalactamase, Digestive tract colonization, Cross-contamination

Brief summary

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Detailed description

Prospective epidemiological study with voluntary non-medical staff member (i.e. nurses and nursing assistants) and medical staff in two French ICUs. Assessment of self-reported risk factors for MDR-bacteria colonization. Self-performed rectal swab with isolation of ESBL-producting Enterobacteriaceae, identification of bacterial species and antibiotic suspectibilities. Characterization of Escherichia coli ESBL.

Interventions

OTHERESBL

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* volunteers

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Digestive tract colonization by ESBL	at day 1	Digestive tract colonization by ESBL-producing Enterobacteriaceae on 1 faeces sample

Countries

France

Contacts

Primary ContactPatrick LACARIN

placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026